جامعة المعرفة
المصدر المعتمد للمعلومات البحثية والمخرجات هو قاعدة بيانات سكوبس (Elsevier Scopus) مع تدقيق بيانات الباحثين من عمادة البحث العلمي.
NM

Nourhan E Mohamed

بانتظار توثيق الانتساب2022–2023
2وثائق Scopus
3استشهاداً
1مؤشر h
0منها بانتماء الجامعة
إجمالي Scopus (كل الجهات)
مقالوصول مفتوح20233استشهاد· Semantic Scholar

Predictors of Mortality in Adults With Sickle Cell Disease Admitted to the Intensive Care Unit in King Saud Medical City, Saudi Arabia

Cureus · مجلد 15 (5) · e38817-e38817

Background Sickle cell disease (SCD) is the most common genetic blood disorder in Saudi Arabia. A limited number of studies have been conducted on SCD patients regarding their intensive care unit (ICU) admissions. We aimed to identify the cause of ICU admission in SCD patients and to identify predictors of mortality. Methodology We identified 64 patients with SCD, aged 14 years and older, who were admitted to the ICU of King Saud Medical City, Riyadh, Kingdom of Saudi Arabia, from January 1, 2017, to December 31, 2020. Results Acute chest syndrome was the most frequent primary diagnosis for ICU admission in 29 (45.3%) patients followed by vaso-occlusive crisis in 23 (35.9%) patients. Pregnancy in eight (12.5%) patients was the most prevalent co-existing condition. The median age was 29 years, with males comprising 45.3% and females comprising 54.7% of the study population. Arterial blood gas pH less than 7.2 on ICU admission (p= <0.001), hemodialysis support (p= 0.049), the use of vasopressors (p= 0.016), intubation (p= <0.001), and being intubated within the first 24 hours of ICU stay (p= 0.04) had a statistically significant association with mortality at ICU discharge out of all the variables tested. Mortality on ICU discharge was 7 (10.9%). Conclusion This was a retrospective study carried out in King Saud Medical City. Comparing the results of the study to those of similar ones conducted around the world revealed a low SCD ICU mortality rate. This low mortality may be a result of improved overall ICU care. We recommend a multi-center, prospective study in future.

sickle cell diseaseintensive care unit admissionmortality risk factorsacute chest syndrome
مقالمفتوح (مستودع)2022

Attitude and practice of physicians in King Khalid University Hospital, regarding placebo 2021-2022

Medical Science · مجلد 26 (129) · 1-9

Background: In the developing world of medicine, placebo treatment has been viewed as a subject of controversy.Some physicians support its' use and advocate its effectiveness while others are against it for various reasons.This study provides identification of the practice of placebo and debates its validity.Methods: A cross-sectional study was conducted in King Khalid University Hospital in Riyadh-Saudi Arabia, targeting doctors from both genders different ages and experiences.190 physicians were chosen by quota sampling technique.The data was collected by a printed survey and distributed manually.SPSS software was used for analyzing.Results: The results showed that age, years of experience and the specialty of the physician doesn't influence their frequency of placebo use or the attitude.However, positive attitude prevailed more among male physicians (p=0.0204).78% of the physicians in this study had positive attitude towards placebo prescription while none showed a negative attitude.80% of residents used placebo used it to calm the patient and 35% as a treatment for nonspecific symptoms.Conclusion: Despite of the ethical controversy of prescribing placebo, a fair number of doctors prescribe it to their patients.This study revealed that there is no significant difference in age, gender, experience, or specialty between doctors who support placebo as a medical treatment compared to those who do not.Our study provides valuable data about the attitudes of physicians towards such a controversial methodology of treatment.

physician attitudesplacebo usemedical ethicsgender differences in physicians